3-carboxy-4-methyl-5-propyl-2-furanpropionic acid has been researched along with Metabolic Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Mello, V; Hanhineva, K; Kolehmainen, M; Lankinen, MA; Lehtonen, M; Mykkänen, H; Paananen, J; Pedret, A; Poutanen, K; Schwab, U; Sola, R; Uusitupa, M | 1 |
Auriola, S; Hanhineva, K; Kolehmainen, M; Lankinen, MA; Lehtonen, M; Mykkänen, H; Poutanen, K; Schwab, U; Uusitupa, M | 1 |
2 trial(s) available for 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid and Metabolic Syndrome
Article | Year |
---|---|
Nontargeted metabolite profiling discriminates diet-specific biomarkers for consumption of whole grains, fatty fish, and bilberries in a randomized controlled trial.
Topics: Animals; Biomarkers; Chromatography, Liquid; Diet; Edible Grain; Fasting; Feeding Behavior; Female; Finland; Fishes; Food, Fortified; Fruit; Furans; Humans; Male; Mass Spectrometry; Metabolic Syndrome; Metabolome; Propionates; Spectrometry, Mass, Electrospray Ionization; Vaccinium myrtillus | 2015 |
CMPF does not associate with impaired glucose metabolism in individuals with features of metabolic syndrome.
Topics: Animals; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Chromatography, Liquid; Diet; Fasting; Fatty Acids, Omega-3; Female; Fishes; Furans; Glucose Tolerance Test; Humans; Insulin; Male; Metabolic Syndrome; Middle Aged; Propionates; Tandem Mass Spectrometry; Triglycerides; Vaccinium myrtillus | 2015 |